ID DEGS2_HUMAN Reviewed; 323 AA. AC Q6QHC5; Q6P492; DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot. DT 24-NOV-2009, sequence version 2. DT 27-MAR-2024, entry version 140. DE RecName: Full=Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2; DE EC=1.14.18.5 {ECO:0000269|PubMed:15063729}; DE EC=1.14.19.17 {ECO:0000269|PubMed:15063729}; DE AltName: Full=Degenerative spermatocyte homolog 2; DE AltName: Full=Sphingolipid 4-desaturase; DE AltName: Full=Sphingolipid C4-monooxygenase; GN Name=DEGS2 {ECO:0000312|HGNC:HGNC:20113}; Synonyms=C14orf66; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, TISSUE SPECIFICITY, RP INDUCTION, AND VARIANT ASN-8. RC TISSUE=Skin {ECO:0000312|EMBL:AAS68362.1}; RX PubMed=15063729; DOI=10.1016/s0014-5793(04)00274-1; RA Mizutani Y., Kihara A., Igarashi Y.; RT "Identification of the human sphingolipid C4-hydroxylase, hDES2, and its RT up-regulation during keratinocyte differentiation."; RL FEBS Lett. 563:93-97(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=12508121; DOI=10.1038/nature01348; RA Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., RA Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., RA Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., RA Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T., RA Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B., RA Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D., RA Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R., RA Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S., RA Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C., RA Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S., RA Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., RA Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., RA Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M., RA Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V., RA Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J., RA Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F., RA Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F., RA Waterston R., Hood L., Weissenbach J.; RT "The DNA sequence and analysis of human chromosome 14."; RL Nature 421:601-607(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-8. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-57. RC TISSUE=Skin {ECO:0000312|EMBL:AAH63598.1}; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Bifunctional enzyme which acts both as a sphingolipid CC delta(4)-desaturase and a sphingolipid C4-monooxygenase. CC {ECO:0000269|PubMed:15063729}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a dihydroceramide + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 = a CC phytoceramide + 2 Fe(III)-[cytochrome b5] + H2O; CC Xref=Rhea:RHEA:55808, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:139048, CC ChEBI:CHEBI:139051; EC=1.14.18.5; CC Evidence={ECO:0000269|PubMed:15063729}; CC -!- CATALYTIC ACTIVITY: CC Reaction=an N-acylsphinganine + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 CC = an N-acylsphing-4-enine + 2 Fe(III)-[cytochrome b5] + 2 H2O; CC Xref=Rhea:RHEA:46544, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:31488, CC ChEBI:CHEBI:52639; EC=1.14.19.17; CC Evidence={ECO:0000269|PubMed:15063729}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2 Fe(II)-[cytochrome b5] + 2 H(+) + N-octanoylsphinganine + O2 CC = 2 Fe(III)-[cytochrome b5] + H2O + N-octanoyl-4-hydroxysphinganine; CC Xref=Rhea:RHEA:43116, Rhea:RHEA-COMP:10438, Rhea:RHEA-COMP:10439, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:82841, CC ChEBI:CHEBI:82842; Evidence={ECO:0000269|PubMed:15063729}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43117; CC Evidence={ECO:0000305|PubMed:15063729}; CC -!- CATALYTIC ACTIVITY: CC Reaction=an N-acylsphinganine + 2 Fe(II)-[cytochrome b5] + 2 H(+) + O2 CC = an N-acyl-(4R)-4-hydroxysphinganine + 2 Fe(III)-[cytochrome b5] + CC H2O; Xref=Rhea:RHEA:46364, Rhea:RHEA-COMP:10438, Rhea:RHEA- CC COMP:10439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:29033, ChEBI:CHEBI:29034, ChEBI:CHEBI:31488, CC ChEBI:CHEBI:31998; EC=1.14.18.5; CC Evidence={ECO:0000269|PubMed:15063729}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46365; CC Evidence={ECO:0000305|PubMed:15063729}; CC -!- PATHWAY: Membrane lipid metabolism; sphingolipid biosynthesis. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:Q8R2F2}; Multi-pass membrane protein CC {ECO:0000250|UniProtKB:Q8R2F2}. CC -!- TISSUE SPECIFICITY: Highly expressed in skin, intestine and kidney. CC {ECO:0000269|PubMed:15063729}. CC -!- INDUCTION: Up-regulated during keratinocyte differentiation. Not CC expressed at the beginning or day 3 after differentiation, detected on CC day 6 and increases by day 9. {ECO:0000269|PubMed:15063729}. CC -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family. DEGS CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY541700; AAS68362.1; -; mRNA. DR EMBL; AL133523; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471061; EAW81688.1; -; Genomic_DNA. DR EMBL; BC063598; AAH63598.1; -; mRNA. DR CCDS; CCDS9956.1; -. DR RefSeq; NP_996801.2; NM_206918.2. DR AlphaFoldDB; Q6QHC5; -. DR BioGRID; 125815; 1. DR STRING; 9606.ENSP00000307126; -. DR SwissLipids; SLP:000000170; -. DR iPTMnet; Q6QHC5; -. DR PhosphoSitePlus; Q6QHC5; -. DR BioMuta; DEGS2; -. DR DMDM; 269849561; -. DR jPOST; Q6QHC5; -. DR MassIVE; Q6QHC5; -. DR PaxDb; 9606-ENSP00000307126; -. DR PeptideAtlas; Q6QHC5; -. DR ProteomicsDB; 67288; -. DR Antibodypedia; 54980; 100 antibodies from 15 providers. DR DNASU; 123099; -. DR Ensembl; ENST00000305631.7; ENSP00000307126.5; ENSG00000168350.8. DR GeneID; 123099; -. DR KEGG; hsa:123099; -. DR MANE-Select; ENST00000305631.7; ENSP00000307126.5; NM_206918.3; NP_996801.2. DR UCSC; uc001ygx.3; human. DR AGR; HGNC:20113; -. DR CTD; 123099; -. DR DisGeNET; 123099; -. DR GeneCards; DEGS2; -. DR HGNC; HGNC:20113; DEGS2. DR HPA; ENSG00000168350; Tissue enhanced (esophagus, intestine, skin). DR MIM; 610862; gene. DR neXtProt; NX_Q6QHC5; -. DR OpenTargets; ENSG00000168350; -. DR PharmGKB; PA134973300; -. DR VEuPathDB; HostDB:ENSG00000168350; -. DR eggNOG; KOG2987; Eukaryota. DR GeneTree; ENSGT00390000013448; -. DR HOGENOM; CLU_032156_0_0_1; -. DR InParanoid; Q6QHC5; -. DR OMA; FEWVYND; -. DR OrthoDB; 5485164at2759; -. DR PhylomeDB; Q6QHC5; -. DR TreeFam; TF313582; -. DR BioCyc; MetaCyc:HS15665-MONOMER; -. DR BRENDA; 1.14.18.5; 2681. DR PathwayCommons; Q6QHC5; -. DR Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis. DR UniPathway; UPA00786; -. DR BioGRID-ORCS; 123099; 11 hits in 1151 CRISPR screens. DR GenomeRNAi; 123099; -. DR Pharos; Q6QHC5; Tbio. DR PRO; PR:Q6QHC5; -. DR Proteomes; UP000005640; Chromosome 14. DR RNAct; Q6QHC5; Protein. DR Bgee; ENSG00000168350; Expressed in upper arm skin and 150 other cell types or tissues. DR ExpressionAtlas; Q6QHC5; baseline and differential. DR GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome. DR GO; GO:0102772; F:sphingolipid C4-monooxygenase activity; IEA:UniProtKB-EC. DR GO; GO:0042284; F:sphingolipid delta-4 desaturase activity; IBA:GO_Central. DR GO; GO:0000170; F:sphingosine hydroxylase activity; TAS:Reactome. DR GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central. DR GO; GO:0006667; P:sphinganine metabolic process; IBA:GO_Central. DR GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome. DR CDD; cd03508; Delta4-sphingolipid-FADS-like; 1. DR InterPro; IPR011388; DES1/DES2. DR InterPro; IPR005804; FA_desaturase_dom. DR InterPro; IPR013866; Sphingolipid_d4-desaturase_N. DR PANTHER; PTHR12879; SPHINGOLIPID DELTA 4 DESATURASE/C-4 HYDROXYLASE PROTEIN DES2; 1. DR PANTHER; PTHR12879:SF21; SPHINGOLIPID DELTA(4)-DESATURASE_C4-MONOOXYGENASE DES2; 1. DR Pfam; PF00487; FA_desaturase; 1. DR Pfam; PF08557; Lipid_DES; 1. DR PIRSF; PIRSF017228; Sphnglp_dlt4_des; 1. DR SMART; SM01269; Lipid_DES; 1. DR Genevisible; Q6QHC5; HS. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Lipoprotein; KW Membrane; Myristate; Oxidoreductase; Reference proteome; Transmembrane; KW Transmembrane helix. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:Q564G3" FT CHAIN 2..323 FT /note="Sphingolipid delta(4)-desaturase/C4-monooxygenase FT DES2" FT /evidence="ECO:0000250|UniProtKB:Q564G3" FT /id="PRO_0000312816" FT TRANSMEM 45..65 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 68..88 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 210..231 FT /note="Helical" FT /evidence="ECO:0000255" FT REGION 95..99 FT /note="Required for C4-hydroxylase activity" FT /evidence="ECO:0000250|UniProtKB:Q8R2F2" FT MOTIF 89..93 FT /note="Histidine box-1" FT /evidence="ECO:0000305" FT MOTIF 128..132 FT /note="Histidine box-2" FT /evidence="ECO:0000305" FT MOTIF 259..263 FT /note="Histidine box-3" FT /evidence="ECO:0000305" FT LIPID 2 FT /note="N-myristoyl glycine" FT /evidence="ECO:0000250|UniProtKB:Q564G3" FT VARIANT 8 FT /note="S -> N (in dbSNP:rs7157599)" FT /evidence="ECO:0000269|PubMed:15063729, ECO:0000269|Ref.3" FT /id="VAR_060347" FT VARIANT 57 FT /note="A -> T (in dbSNP:rs4905937)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_055698" SQ SEQUENCE 323 AA; 37197 MW; 4726A4EBD357EB0F CRC64; MGNSASRSDF EWVYTDQPHT QRRKEILAKY PAIKALMRPD PRLKWAVLVL VLVQMLACWL VRGLAWRWLL FWAYAFGGCV NHSLTLAIHD ISHNAAFGTG RAARNRWLAV FANLPVGVPY AASFKKYHVD HHRYLGGDGL DVDVPTRLEG WFFCTPARKL LWLVLQPFFY SLRPLCVHPK AVTRMEVLNT LVQLAADLAI FALWGLKPVV YLLASSFLGL GLHPISGHFV AEHYMFLKGH ETYSYYGPLN WITFNVGYHV EHHDFPSIPG YNLPLVRKIA PEYYDHLPQH HSWVKVLWDF VFEDSLGPYA RVKRVYRLAK DGL //